Clinical Trial Update: A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy [Phase 2]

View source ↗

Summary

A Phase 2 study of TAK-994 in adults with Narcolepsy Type 1 and Type 2 was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• TAK-994

Snippet

Sponsor: Takeda | Conditions: Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2) | Phase 2 | Status: TERMINATED | Results posted: 2024-10-29